Enzyme mitogen activated protein kinases

The catalytic activity of cPLA2 is stimulated by phosphorylation catalyzed by the mitogen-activated protein kinase (MAPK) at Ser505. This modification stimulates enzyme activity only, indicating that translocation and phosphorylation are independent mechanisms of cPLA2 regulation [21]. 

Figure 21.9 The mitogen-activated protein kinase cascade (MAP kinase cascade). The active protein Ras activates Raf by promoting its recruitment to a cell membrane. Through a series of phosphorylations MAP kinase is activated as follows MAP kinase kinase kinase (Raf) phosphorylates MAP kinase kinase which, in turn, phosphorylates MAP kinase, the final target enzyme. MAP kinase phosphorylates transcription factors for genes that express proteins involved in proliferation. Another nomenclature for the enzymes is also used raf is MEKK MAPKK is MEK and finally ERK is MAP kinase (ERK is the abbreviation for extracellular-signal-related kinase) For comparison, the reader is referred to the metabolic phosphorylase cascade, which is discussed in Chapter 12 (Figure 12.12).

The potential substrates for histone phosphorylation include N-terminal serine and threonine hydroxyl groups of H2A, H3, and H4 the N- and C-terminal tails of HI and the unique C-terminal of H2AX [19,29] (see Fig. 6). Similar to acetylation, phosphorylation appears to be a dynamic modification that transduces on/off signals to nuclear modulators. Enzymes implicated in regulating this pathway include the cyclin-dependent kinases and mitogen activated protein kinases, and the antagonistic phosphatase 1 [158,159]. 

Two processes have been proposed to explain the mitogenic effect of fluoride on bone cells involving either fluoride ions directly or the AIF complex (Fig. 11). Fluoride ions have been shown to directly inhibit an enzyme (tyrosine phophory-lase phosphatase) resulting in an enhancement of the tyrosine phosphorylation part of the mitogen-activated protein kinase system (MARK) [177], The other activation pathway involves a complex of aluminium and fluoride which activates the G-protein and stimulates tyrosine phophorylation resulting in an enhanced mitogenic effect [176]. 

Another important family of kinases for drug discovery is the mitogen-activated protein kinases (MAPKs). These are proline-directed serine/threonine kinases that activate their substrates by dual-phosphorylation. MAPK enzymes are activated by a variety of signals including growth factors and cytokines, discussed in chapter 6. The MAPK family plays a critical role in cell cycle progression. Small molecule inhibitors of MAPK may have utility in the treatment of cancer. 

Mitogen activated protein kinase (MAPK) An enzyme involved in cellular regulation it is activated by an extracellular signal (mitogen) and catalyzes the addition of a phosphate to a biomolecule. 

There are numerous data that peroxynitrite is involved in cell death and tissue injuries in many clinical conditions. An important mechanism underlying peroxynitrite toxicity is the reaction of tyrosine nitration. Tyrosine nitration inactivates certain enzymes, as was postulated for prostacyclin (PGI2) synthase (M14), cytochrome P450 2B1 (RIO), tyrosine hydroxylase (A 14), and MnSOD (Yl). Moreover, nitration blocks tyrosine phosphorylation, and thus interferes with the tyrosine kinase signaling pathways (K18). The peroxynitrite treatment of rat liver epithelial cells stimulates mitogen-activated protein kinases p38 MAPK, JNK1/2, and ERK1/2 the mechanism of this effect awaits elucidation (S9). 

If we concentrate on one particular component of this map - the phosphorylation of PI(4,5)P2 to PI(3,4,5)P3 by PI3K and the dephosphorylation of PI(3,4,5)P3 to PI(4,5)P2 by F TEN, we can study the detailed enzyme kinetic scheme of this so-called phosphorylation-dephosphorylation cycle, which is illustrated in Figure 5.2. This illustrated cycle represents a ubiquitous module in biochemical signaling, ft could, for example, represent the phosphorylation of mitogen-activation protein kinase (MAPK) by MAPK kinase (MAPKK) and dephosphorylation of MAPK by MAPK phosphatase (MKP). 

Essentially, all organ systems must be evaluated. Thus laboratory tests, should include complete blood count, liver and renal functional tests, and blood, nail and urine arsenic levels. Other biomarkers of arsenic exposure include nonerythrocyte porphyrin enzyme activities and urine transforming growth factor TNF-a, accompanied by induction of heme oxygenase, mitogen-activated protein kinases, the ubiquitin-dependent proteolytic pathway, and protein kinase C in various tissues. These tests are still being investigated in laboratories and their clinical usefulness remains to be proven (Chapell et al, 2001). 

---